|Bid||310.30 x 0|
|Ask||310.40 x 0|
|Day's Range||306.20 - 314.60|
|52 Week Range||196.15 - 701.80|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||10.97|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar. 19, 2020|
|1y Target Est||N/A|
The company, which makes parts used in planes, said revenue from its civil aerospace business is expected to decline about 30% in the first half, following a roughly 50% fall in the second quarter. Meggitt said its defence business continued to perform well but gains would be offset by the declines in its civil aerospace and energy units.
British engineering company Meggitt <MGGT.L> said it planned to shed about 1,800 jobs as part of a cost cutting plan to cope with a contraction in the world's air travel market due to the coronavirus pandemic. Meggitt, which makes parts used in planes, said on Thursday that it was too early to provide guidance for this year given the coronavirus crisis, and its focus was on cutting costs. The company said that it would cut jobs equivalent to 15% of its global workforce of 12,000 people, but a spokesman said there was no clarity on where those jobs would be lost.
(Bloomberg) -- When Britain’s government issued an urgent call to industry for thousands of hospital ventilators, more than 5,000 companies offered to help. Coronavirus infections are expected to peak next week and there’s little to show for their effort.Significant deliveries from the firms are still weeks away, and the embattled National Health Service has resorted to foreign imports and loans from the armed forces and the private sector to double its ventilator count to around 10,000. While the national lockdown appears to be slowing the spread of Covid-19, the NHS may need as many as 8,000 more of the devices, according to Health Secretary Matt Hancock.The government is under intense pressure to solve Britain’s shortage of the machines that are vital for treating critically ill patients. It already spurned an offer to join a European Union program for procuring ventilators, initially stating it was no longer a member of the bloc and could source them locally, before backtracking and saying it had missed the email inviting participation. EU leaders are struggling to coordinate a response to the virus; last night they were unable to agree on a 500 billion-euro ($543 billion) stimulus package.It’s not that U.K. Plc can’t do the job: The machines are seen as relatively straightforward to make and much of industry has been sitting on its hands since the economy tanked. The problem is that vacuum cleaner maker Dyson Ltd., engineering contractor Babcock International Group Plc and other newcomers to the business need their designs to be fully tested and approved.It can take months for the U.K. Medicines & Healthcare Products Regulatory Agency to sign off on sensitive medical machinery. The process can be expedited, but still takes valuable time to ensure patients’ safety.“It’s a race against the clock,” said Derek Hill, a professor specializing in medical devices at University College London. The regulator is “literally working all hours making this happen fast.”For now, the supply of ventilators from British manufacturers is tiny. The NHS expects to receive 30 locally-made machines this week, compared to 300 sourced from China over the weekend.Department of Health and Social Care officials say they are confident there will be enough ventilators to meet demand, given the steps being taken to increase the number available, and as long as people continue to stay at home to reduce the spread of the virus.Pistons, TurbochargersIn the short run, the greatest hope lies with consortium Ventilator Challenge UK, which includes Meggitt Plc, Airbus SE, GKN Ltd, McLaren Automotive Ltd and Rolls-Royce Holdings Plc. They plan to churn out 1,500 ventilators a week using designs from Penlon Ltd. and Smiths Group Plc, two medical device makers that can currently only make about 50 to 60 of the machines per week on their own. The group already has an approved ventilator from Smiths. But it’s still closing in on final approval for the other, and its factories and supply chains are in need of re-calibrating, so large deliveries are unlikely before the end of April.A breathing aid developed by engineers from the Mercedes Formula One team and University College London has been approved for use. It’s being manufactured at a rate of as many as 1,000 a day using machines that would normally produce racing car pistons and turbochargers. It’s not as sophisticated as a ventilator, but it can help reduce the need for those devices.Companies such as Babcock -- which has a government contract to make 10,000 of its Zephyr Plus ventilators -- face a longer wait for approval. They may end up being useful in a potential second or third wave of infection.Prime Minister Boris Johnson, who is in hospital with the disease, set a challenge last month to source 30,000 ventilators.The government now says fewer will be needed because lockdown measures have slowed the virus’s spread. The NHS has 2,000 extra ventilators on standby, with 1,500 more due to arrive by the end of the week, Hancock said on Sunday.(Updates with news on EU fiscal stimulus in third paragraph; adds context)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
LONDON/MILAN (Reuters) - From Washington to London, Beijing to Rome, governments are drafting automakers and aerospace manufacturers to ramp up production of ventilators and other medical equipment to bolster what most experts say is an inadequate arsenal of coronavirus treatment tools. Authorities are hoping large-scale manufacturers can use their low-cost supply chains and digital design expertise, including 3D printing, and repurpose some factories in order to make up the expected shortfall in vital medical hardware. Some of Britain's biggest aerospace and car companies have formed three teams to produce basic ventilators to help the country's National Health Service cope with the coronavirus outbreak.
Assessing Meggitt PLC's (LSE:MGGT) past track record of performance is a valuable exercise for investors. It enables...
Britain's Meggitt <MGGT.L> warned that future growth would be constrained by the halt to production of Boeing's <BA.N> 737 MAX aircraft and the economic impact of the coronavirus, knocking its shares. For 2020, Meggitt, which makes aerospace parts, said that organic revenue growth would be between 2% and 4%, trailing the 8% rise recorded last year, while underlying operating profit would take a 20 million pound ($26 million) hit from the two factors. The impact was split equally, with 10 million pounds from the Boeing issues and 10 million pounds from the rapid spread of the COVID-19 virus, mainly as a result of the drop in air traffic, Meggitt CEO Tony Wood said.
One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...
Dividend paying stocks like Meggitt PLC (LON:MGGT) tend to be popular with investors, and for good reason - some...
The company, which supplies aerospace components and wheels and brakes for military fighter programmes, said it expects full year organic revenue growth between 6% and 7%, up from an earlier view of 4% to 6%. Meggitt is a key supplier to Airbus <AIR.PA> and Boeing, which earlier this year said it would cut production of its 737 MAX aircraft as it struggles with the worldwide grounding of the narrowbody jet following two fatal crashes in less than five months.
Meggitt PLC (LON:MGGT) is about to trade ex-dividend in the next 3 days. You will need to purchase shares before the...